Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA OTC drug of abuse testing policy to cover workplace, insurance, other sites.

This article was originally published in The Tan Sheet

Executive Summary

OTC DRUGS OF ABUSE TEST POLICY WILL COVER ALL NONPROFESSIONAL SETTINGS, FDA Deputy Commissioner for Policy William Schultz said Feb. 6 at a House Commerce/Oversight Subcommittee hearing. Noting the importance of assuring "accurate, reliable results" of drugs of abuse tests in all nonprofessional settings, Schultz said FDA would apply its policy to workplace, insurance, and sports testing as well as home testing.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS086656

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel